Prof. Dr. med. Gesine Hansen
is the Medical Director of the Clinic for Pediatric Pneumology, Allergology and Neonatology at Hannover Medical School. After studying human medicine at the Ruhr-Universität-Bochum and the Charing Cross and Westminster Medical School London, she completed her specialist training as a pediatrician at the University of Düsseldorf from 1992 to 1997. From 1997-1999 she was awarded a DFG scholarship for a research stay at Stanford University at the Institute of Immunology and Transplantation Medicine. Here the foundations for her immunologically based allergy research were laid, which she continued at the Martin-Luther-University as head of a BMBF junior research group. Clinically, she was head of the section pediatric pneumology and allergology at the University Children's Hospital as senior physician and
C3 professor. After calls to the University of Bonn and the Charité in Berlin, she was appointed to the W3 Professorship for General Pediatrics at the Hannover Medical School (MHH) in 2005. In 2006 she became Medical Director of the Center for Pediatrics and Adolescent Medicine at the MHH.
In addition to her tasks in clinic, research and teaching, she is also involved as spokesperson of the Collaborative Research Center 587 of the German Research Foundation, spokesperson of the TITUS research college of the Else Kröner-Fresenius Foundation, vice spokesperson of the Excellence Cluster RESIST, board member of the German Center for Lung Diseases (DZL; Breath), President of the Society for Paediatric Pneumology, Senator of the MHH, member of the Research Commission of the MHH and member of the Advisory Board of the NGFN of the BMBF Gesine Hansen is an elected member of the National Academy of Sciences.
Scientific focus of Gesine Hansen is the investigation of immunological mechanisms in the development of allergy and tolerance. The aim of her research is the development of preventive and therapeutic approaches for allergic diseases. Special attention has been paid to her work on regulatory T cells and on already perinatal formative immunological influences on allergy risk or other disease risks. Further research focuses on the development of new technologies for comprehensive cell characterization and the development of cell-based therapies for pulmonary diseases. In addition, she is interested in respiratory infections and was instrumental in establishing a cohort for early, severe RSV infection (IRIS) and a cohort for ambulatory acquired pneumonia (pedCAPNETZ). Research work of Gesine Hansen was awarded among others the "International Allergy Research Award", the "Karl Hansen Memorial Prize" of the German Society for Allergology and Clinical Immunology, the "Adalbert Czerny Prize" of the German Society for Pediatrics and Youth Medicine, the "Johannes Wenner Prize" of the Society for Pediatric Pneumology and the "Eva Luise Köhler Prize" for rare diseases.